METHOD FOR SELECTING THROMBOCYTOPATHY TREATMENT APPROACH IN METABOLIC SYNDROME CASES Russian patent published in 2006 - IPC G01N33/86 G01N33/49 

FIELD: medicine.

SUBSTANCE: method involves determining bleeding duration, adhesion-aggregation capacity of blood platelets, their aggregation function on glass with a row of inductors and their combinations, intravascular activity of blood platelets and blood clot retraction. Study results are processed by applying general multi-dimensional factor analysis approach, transforming each indices under study into comparable relative values calculated with weights determined for each of them with mean-square deviation calculated for each index and multiplied by 0.1. General aggregation potential is calculated and thrombocytopathy treatment method is selected on the basis of this value. The general aggregation potential value belonging to interval of 0.050-0.150, low-calorie diet is to be prescribed. The value belonging to interval of 0.151-0.250, low-calorie diet combined with exercise stress is to be prescribed. The value belonging to interval of 0.251-0.350, Metamorphine is to be prescribed. The value being greater than 0.350, low-calorie diet, exercise stress and Metamorphine are to be prescribed in combination.

EFFECT: high quality of treatment method selection.